drugset / Trial / NCT02206490

Trial of Naltrexone and Dextromethorphan for Gulf War Illness

NCT02206490

Phase 2 Completed 60 enrolled East Carolina University
RandomizedCrossoverQuadruple-blindTreatment

Summary

Veterans of the 1991 Gulf War who developed Gulf War Illness are being studied. Treatments with FDA approved generic drugs are being administered to see if they help with the symptoms of Gulf War Illness, such as chronic fatigue; difficulty with memory, concentration, and thinking; widespread chronic pain; and autonimic dysfunction. Drugs to be tested are dextromethorphan and naltrexone.

Timeline

Start
2012-01
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dextromethorphan Unknown
Comparator Naltrexone Small molecule 4.5 mg

Indications